U.S. Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Tenaya Therapeutics

Market Cap: US$82.0m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

Protara Therapeutics

Market Cap: US$153.3m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Pacira BioSciences

Market Cap: US$1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Septerna

Market Cap: US$279.5m

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Trevi Therapeutics

Market Cap: US$599.4m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough conditions targeting the central and peripheral nervous systems.

Mural Oncology

Market Cap: US$41.5m

Operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer.

Amylyx Pharmaceuticals

Market Cap: US$343.8m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

MacroGenics

Market Cap: US$79.5m

A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.

ProKidney

Market Cap: US$207.8m

A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.

Ensysce Biosciences

Market Cap: US$3.1m

A clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.

Context Therapeutics

Market Cap: US$75.6m

A biopharmaceutical company, develops products for the treatment of solid tumors.

GH Research

Market Cap: US$557.6m

Together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States.

Boundless Bio

Market Cap: US$30.1m

A clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA.

Ventyx Biosciences

Market Cap: US$79.0m

A clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases.

RenovoRx

Market Cap: US$32.9m

A clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.

Silence Therapeutics

Market Cap: US$132.2m

A biotechnology company, engages in the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Niagen Bioscience

Market Cap: US$498.3m

Operates as a bioscience company engages in developing healthy aging products.

Vanda Pharmaceuticals

Market Cap: US$254.8m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Dianthus Therapeutics

Market Cap: US$617.1m

A clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases.

Dermata Therapeutics

Market Cap: US$4.2m

A late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications.

Aldeyra Therapeutics

Market Cap: US$131.4m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

180 Life Sciences

Market Cap: US$4.6m

A clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases.

Kyverna Therapeutics

Market Cap: US$85.8m

Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases.

Qiagen

Market Cap: US$9.0b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Passage Bio

Market Cap: US$22.9m

A genetic medicines company, develops gene therapies for central nervous system diseases.

Anbio Biotechnology

Market Cap: US$280.0m

Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.

Barinthus Biotherapeutics

Market Cap: US$27.5m

A clinical-stage biopharmaceutical company, engages in development of novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer.

Exicure

Market Cap: US$73.9m

Does not have significant operations.

4D Molecular Therapeutics

Market Cap: US$143.5m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Sagimet Biosciences

Market Cap: US$69.9m

A clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States.

Stevanato Group

Market Cap: US$6.2b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Astria Therapeutics

Market Cap: US$231.4m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

HilleVax

Market Cap: US$81.2m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States.

Nurix Therapeutics

Market Cap: US$748.6m

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

ImmunoPrecise Antibodies

Market Cap: US$18.8m

A techbio company, engages in the development of therapeutic antibodies.

Aptevo Therapeutics

Market Cap: US$3.1m

A clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.